Unknown

Dataset Information

0

Recombinant lambda-phage nanobioparticles for tumor therapy in mice models.


ABSTRACT: Lambda phages have considerable potential as gene delivery vehicles due to their genetic tractability, low cost, safety and physical characteristics in comparison to other nanocarriers and gene porters. Little is known concerning lambda phage-mediated gene transfer and expression in mammalian hosts. We therefore performed experiments to evaluate lambda-ZAP bacteriophage-mediated gene transfer and expression in vitro. For this purpose, we constructed recombinant lambda-phage nanobioparticles containing a mammalian expression cassette encoding enhanced green fluorescent protein (EGFP) and E7 gene of human papillomavirus type 16 (lambda-HPV-16 E7) using Lambda ZAP- CMV XR vector. Four cell lines (COS-7, CHO, TC-1 and HEK-239) were transduced with the nanobioparticles. We also characterized the therapeutic anti-tumor effects of the recombinant lambda-HPV-16 E7 phage in C57BL/6 tumor mice model as a cancer vaccine. Obtained results showed that delivery and expression of these genes in fibroblastic cells (COS-7 and CHO) are more efficient than epithelial cells (TC-1 and HEK-239) using these nanobioparticles. Despite the same phage M.O.I entry, the internalizing titers of COS-7 and CHO cells were more than TC-1 and HEK-293 cells, respectively. Mice vaccinated with lambda-HPV-16 E7 are able to generate potent therapeutic antitumor effects against challenge with E7- expressing tumor cell line, TC-1 compared to group treated with the wild phage. The results demonstrated that the recombinant lambda-phages, due to their capabilities in transducing mammalian cells, can also be considered in design and construction of novel and safe phage-based nanomedicines.

SUBMITTER: Ghaemi A 

PROVIDER: S-EPMC2890663 | BioStudies | 2010-01-01

REPOSITORIES: biostudies

Similar Datasets

1000-01-01 | S-EPMC3690484 | BioStudies
2009-01-01 | S-EPMC2647576 | BioStudies
2013-01-01 | S-EPMC3783646 | BioStudies
1000-01-01 | S-EPMC4738102 | BioStudies
2011-01-01 | S-EPMC3135274 | BioStudies
2015-01-01 | S-EPMC4577214 | BioStudies
2019-01-01 | S-EPMC6535840 | BioStudies
| GSE46304 | GEO
2009-01-01 | S-EPMC2758704 | BioStudies
2015-01-01 | S-EPMC4586868 | BioStudies